Capecitabine medac 150 mg (500 mg) film-coated tablets
Each film-coated tablet contains 150 mg (500 mg) of capecitabine.
Capecitabine medac is indicated for the treatment of metastatic colorectal cancer.
Capecitabine medac is indicated for first-line treatment of advanced gastric cancer in combination with a platinum based regimen.
Capecitabine medac in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline. Capecitabine medac is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.
Pack sizes:
150 mg N60
500 mg N 120
150 mg N60
500 mg N 120
